In development: Guidance, quality standards and advice
Showing 11 to 11 of 11
| Title | Type | Expected publication date |
|---|---|---|
| Vorasidenib for treating astrocytoma or oligodendroglioma with IDH1 or IDH2 mutations after surgery in people 12 years and over [ID6407] | Technology appraisal guidance |